Cera Sanitaryware Limited reported a strong 11.4% year-on-year revenue growth in Q4 FY2026, reaching INR 644 crore. Despite margin pressures from elevated input costs and trade discounts, the company noted improved demand traction in retail and project segments. Management expressed confidence in future performance, forecasting 18% to 20% revenue growth for FY2027, driven by a recovery in core segments and the scaling of emerging brands, Senator and Polipluz.
Quarterly Financial Highlights
Cera Sanitaryware delivered a resilient financial performance for the quarter ended 31st March 2026. Revenue from operations grew to INR 644 crore, compared to INR 578 crore in the corresponding quarter of the previous year. Profit after tax stood at INR 77 crore, while Earnings Per Share (EPS) was INR 59.96. EBITDA margins for the quarter were 15.2%, reflecting an improvement from 10.2% recorded in Q3 FY2026.
Operational Performance and Segment Insights
The company’s core business remains robust, with sanitaryware and faucetware accounting for 89% of total revenues. Sanitaryware revenue grew by 10.7%, while faucetware saw a significant increase of 24.3% on a year-on-year basis. Capacity utilization during the quarter reached 70% for sanitaryware and 106% for faucetware. To meet increasing demand, the company is undertaking a capacity expansion for faucetware to reach 5 lakh pieces per month with a minimal capital expenditure of INR 4 to 5 crore.
Strategic Focus and Brand Expansion
Cera continues to invest in its brand architecture, specifically the premium Senator and mass-market Polipluz brands. In FY2026, Senator generated INR 10.5 crore, and Polipluz generated INR 8.5 crore. The company has set ambitious targets for these brands, projecting a combined revenue contribution of INR 70 to 80 crore in FY2027. The expansion strategy includes increasing the number of Senator flagship stores to 60 and expanding the Polipluz distributor network to 200 by the end of FY2027.
Future Outlook and Capital Strategy
Management remains optimistic about FY2027, anticipating an overall revenue growth of 18% to 20%. This growth is expected to be supported by a normalization of trade discounts and a balanced recovery across urban and rural markets. With a strong cash position of INR 853 crore as of March 2026, the company plans to focus on disciplined capital allocation, including a greenfield sanitaryware project and continued investments in infrastructure, while maintaining healthy dividend distributions to shareholders.
Source: BSE
